Integra LifeSciences announced MicroMatrix Flex is now available commercially in the U.S. MicroMatrix Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix paste to provide convenient access to hard-to-reach spaces and to help prepare an even wound surface in challenging wound areas.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IART:
- Integra LifeSciences price target lowered to $42 from $45 at BofA
- Integra LifeSciences price target lowered to $49 from $55 at JMP Securities
- Integra LifeSciences price target lowered to $45 from $49 at Wells Fargo
- Integra Lifesciences Announces CEO Transition and New Executive Chairman
- Integra LifeSciences CEO Jan De Witte to retire by the end of 2024
